CliffBio
small molecule

HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX

CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX

Loss of exclusivity—loss of exclusivity
CompanyTris. →See this company's full patent-cliff portfolio

Drug detail

Brand nameHYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX
Active ingredientCHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX
StrengthEQ 8MG MALEATE/5ML;EQ 10MG BITARTRATE/5ML
Dosage formSUSPENSION, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalOctober 2010
Marketing statusRX

More from Tris.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX patent cliff — loss of exclusivity — | CliffBio